{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T10:06:03Z","timestamp":1779271563599,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Asian Journal of Psychiatry"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.ajp.2019.101918","type":"journal-article","created":{"date-parts":[[2019,12,26]],"date-time":"2019-12-26T12:49:12Z","timestamp":1577364552000},"page":"101918","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"special_numbering":"C","title":["ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients"],"prefix":"10.1016","volume":"48","author":[{"given":"Naveen","family":"M","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amol N.","family":"Patil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Smita","family":"Pattanaik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anit","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dibyajyoti","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandeep","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajp.2019.101918_bib0005","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","article-title":"Remission in schizophrenia: proposed criteria and rationale for consensus","volume":"162","author":"Andreasen","year":"2005","journal-title":"Am. J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.101918_bib0010","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2174\/1871525715666170529091921","article-title":"Thiopurine S-Methyltransferase as a pharmacogenetic biomarker: significance of testing and review of major methods","volume":"15","author":"Asadov","year":"2017","journal-title":"Cardiovasc. Hematol. Agents Med. Chem."},{"key":"10.1016\/j.ajp.2019.101918_bib0015","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/ajmg.b.30770","article-title":"Lack of association between DRD3 gene polymorphism and response to clozapine in Turkish schizoprenia patients","volume":"150B","author":"Barlas","year":"2009","journal-title":"Am. J. Med. Genet. Part B Neuropsychiatr. Genet. Off. Publ. Int. Soc. Psychiatr. Genet."},{"key":"10.1016\/j.ajp.2019.101918_bib0020","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2217\/pgs.09.51","article-title":"ABCB1 polymorphisms are associated with clozapine plasma levels in psychotic patients","volume":"10","author":"Consoli","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/j.ajp.2019.101918_bib0025","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s11095-016-2091-1","article-title":"Are polymorphisms in genes relevant to drug disposition predictors of susceptibility to drug-induced liver injury?","volume":"34","author":"Daly","year":"2017","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ajp.2019.101918_bib0030","doi-asserted-by":"crossref","first-page":"323","DOI":"10.31887\/DCNS.2016.18.3\/jbishop","article-title":"Pharmacogenetic tests for antipsychotic medications: clinical implications and considerations","volume":"18","author":"Eum","year":"2016","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ajp.2019.101918_bib0035","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4103\/0019-5545.196703","article-title":"Indian psychiatric society multicentric study: correlates of prescription patterns of psychotropics in India","volume":"58","author":"Grover","year":"2016","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.101918_bib0040","doi-asserted-by":"crossref","first-page":"168","DOI":"10.4103\/0019-5545.64592","article-title":"Indian research: focus on clozapine","volume":"52","author":"Grover","year":"2010","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.101918_bib0045","doi-asserted-by":"crossref","first-page":"19","DOI":"10.4103\/0019-5545.196973","article-title":"Clinical practice guidelines for management of schizophrenia","volume":"59","author":"Grover","year":"2017","journal-title":"Indian J. Psychiatry"},{"key":"10.1016\/j.ajp.2019.101918_bib0050","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.ygeno.2013.02.002","article-title":"Identifying a predictive model for response to atypical antipsychotic monotherapy treatment in south Indian schizophrenia patients","volume":"102","author":"Gupta","year":"2013","journal-title":"Genomics"},{"key":"10.1016\/j.ajp.2019.101918_bib0055","series-title":"StatPearls","article-title":"Clozapine","author":"Haidary","year":"2019"},{"key":"10.1016\/j.ajp.2019.101918_bib0060","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/484963","article-title":"Bypassing P-Glycoprotein drug efflux mechanisms: possible applications in pharmacoresistant schizophrenia therapy","volume":"2015","author":"Hoosain","year":"2015","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ajp.2019.101918_bib0065","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/JCP.0b013e3181acc372","article-title":"ABCB1 and cytochrome P450 polymorphisms: clinical pharmacogenetics of clozapine","volume":"29","author":"Jaquenoud Sirot","year":"2009","journal-title":"J. Clin. Psychopharmacol."},{"key":"10.1016\/j.ajp.2019.101918_bib0070","first-page":"8","article-title":"Chapter 7: pharmacogenomics","author":"Karczewski","year":"2012","journal-title":"PLoS Comput. Biol."},{"key":"10.1016\/j.ajp.2019.101918_bib0075","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/3163502","article-title":"Population pharmacokinetics of clozapine and Norclozapine and switchability assessment between brands in Uruguayan patients with schizophrenia","volume":"2019","author":"Olmos","year":"2019","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.ajp.2019.101918_bib0080","first-page":"51","article-title":"Clinical predictors of response to clozapine in patients with treatment resistant schizophrenia","volume":"44","author":"Rajkumar","year":"2011","journal-title":"Psychopharmacol. Bull."},{"key":"10.1016\/j.ajp.2019.101918_bib0085","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/bcpt.13031","article-title":"Effect of ABCB1 C3435T polymorphism on pharmacokinetics of antipsychotics and antidepressants","volume":"123","author":"Saiz-Rodr\u00edguez","year":"2018","journal-title":"Basic Clin. Pharmacol. Toxicol."},{"key":"10.1016\/j.ajp.2019.101918_bib0090","first-page":"9","article-title":"Biological predictors of clozapine response: a systematic review","author":"Samanaite","year":"2018","journal-title":"Front. Psychiatry"},{"key":"10.1016\/j.ajp.2019.101918_bib0095","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S0924-977X(99)00044-9","article-title":"Dopamine D3 receptor gene polymorphism and response to clozapine in schizophrenic Pakastani patients","volume":"10","author":"Scharfetter","year":"1999","journal-title":"Eur. Neuropsychopharmacol. J. Eur. Coll. Neuropsychopharmacol."},{"key":"10.1016\/j.ajp.2019.101918_bib0100","first-page":"602","article-title":"Dopamine receptor pharmacology","volume":"6","author":"Seeman","year":"1993","journal-title":"Curr. Opin. Neurol. Neurosurg."},{"key":"10.1016\/j.ajp.2019.101918_bib0105","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/ajcp\/aqw049","article-title":"Warfarin pharmacogenetics reevaluated subgroup analysis reveals a likely underestimation of the maximum pharmacogenetic benefit by clinical trials","volume":"145","author":"Stack","year":"2016","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.ajp.2019.101918_bib0110","doi-asserted-by":"crossref","first-page":"355","DOI":"10.3389\/fnins.2019.00355","article-title":"Polymorphisms in dopaminergic genes in schizophrenia and their implications in motor deficits and antipsychotic treatment","volume":"13","author":"Ye","year":"2019","journal-title":"Front. Neurosci."}],"container-title":["Asian Journal of Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187620181931295X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S187620181931295X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T16:33:15Z","timestamp":1761755595000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S187620181931295X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":22,"alternative-id":["S187620181931295X"],"URL":"https:\/\/doi.org\/10.1016\/j.ajp.2019.101918","relation":{},"ISSN":["1876-2018"],"issn-type":[{"value":"1876-2018","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ABCB1 and DRD3 polymorphism as a response predicting biomarker and tool for pharmacogenetically guided clozapine dosing in Asian Indian treatment resistant schizophrenia patients","name":"articletitle","label":"Article Title"},{"value":"Asian Journal of Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajp.2019.101918","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101918"}}